| Dr Alfredo Guillermo Antonetti, MD | |
|
1135 N Bishop Ave, Dallas, TX 75208-4114 | |
| (214) 942-3100 | |
| (214) 948-3697 |
| Full Name | Dr Alfredo Guillermo Antonetti |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 1135 N Bishop Ave, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043237761 | NPI | - | NPPES |
| 183629801 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | M2248 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Women's Specialty Center Pa | 0244270411 | 4 |
News Archive
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), offers patients with very restricted diets an easy to use meal planning tool and recipes for their favorite Thanksgiving dinners at DaVita.com.
National HealthCare Corporation, a publicly traded long-term health care company, today announced net income available to common shareholders for the quarter ended March 31, 2012 of $10,508,000 compared to $16,556,000 for the quarter ended March 31, 2011, a decrease of 36.5%.
By the time people with Alzheimer's disease start exhibiting difficulty remembering and thinking, the disease has been developing in their brains for two decades or more, and their brain tissue already has sustained damage. As the disease progresses, the damage accumulates, and their symptoms worsen.
Treatment with intravenous low-molecular-weight iron dextran seems to be an effective alternative for patients with nondialysis chronic kidney disease who remain anemic despite receiving oral iron and erythropoiesis-stimulating agents.
› Verified 2 days ago
| Entity Name | Physician Associates Of Southwest Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801845425 PECOS PAC ID: 3274519293 Enrollment ID: O20040629000498 |
News Archive
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), offers patients with very restricted diets an easy to use meal planning tool and recipes for their favorite Thanksgiving dinners at DaVita.com.
National HealthCare Corporation, a publicly traded long-term health care company, today announced net income available to common shareholders for the quarter ended March 31, 2012 of $10,508,000 compared to $16,556,000 for the quarter ended March 31, 2011, a decrease of 36.5%.
By the time people with Alzheimer's disease start exhibiting difficulty remembering and thinking, the disease has been developing in their brains for two decades or more, and their brain tissue already has sustained damage. As the disease progresses, the damage accumulates, and their symptoms worsen.
Treatment with intravenous low-molecular-weight iron dextran seems to be an effective alternative for patients with nondialysis chronic kidney disease who remain anemic despite receiving oral iron and erythropoiesis-stimulating agents.
› Verified 2 days ago
| Entity Name | Women's Specialty Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174553416 PECOS PAC ID: 0244270411 Enrollment ID: O20050506000258 |
News Archive
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), offers patients with very restricted diets an easy to use meal planning tool and recipes for their favorite Thanksgiving dinners at DaVita.com.
National HealthCare Corporation, a publicly traded long-term health care company, today announced net income available to common shareholders for the quarter ended March 31, 2012 of $10,508,000 compared to $16,556,000 for the quarter ended March 31, 2011, a decrease of 36.5%.
By the time people with Alzheimer's disease start exhibiting difficulty remembering and thinking, the disease has been developing in their brains for two decades or more, and their brain tissue already has sustained damage. As the disease progresses, the damage accumulates, and their symptoms worsen.
Treatment with intravenous low-molecular-weight iron dextran seems to be an effective alternative for patients with nondialysis chronic kidney disease who remain anemic despite receiving oral iron and erythropoiesis-stimulating agents.
› Verified 2 days ago
| Entity Name | Stella Mattina Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487301230 PECOS PAC ID: 5294116091 Enrollment ID: O20220725001732 |
News Archive
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), offers patients with very restricted diets an easy to use meal planning tool and recipes for their favorite Thanksgiving dinners at DaVita.com.
National HealthCare Corporation, a publicly traded long-term health care company, today announced net income available to common shareholders for the quarter ended March 31, 2012 of $10,508,000 compared to $16,556,000 for the quarter ended March 31, 2011, a decrease of 36.5%.
By the time people with Alzheimer's disease start exhibiting difficulty remembering and thinking, the disease has been developing in their brains for two decades or more, and their brain tissue already has sustained damage. As the disease progresses, the damage accumulates, and their symptoms worsen.
Treatment with intravenous low-molecular-weight iron dextran seems to be an effective alternative for patients with nondialysis chronic kidney disease who remain anemic despite receiving oral iron and erythropoiesis-stimulating agents.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alfredo Guillermo Antonetti, MD 1135 N Bishop Ave, Dallas, TX 75208-4114 Ph: (214) 942-3100 | Dr Alfredo Guillermo Antonetti, MD 1135 N Bishop Ave, Dallas, TX 75208-4114 Ph: (214) 942-3100 |
News Archive
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), offers patients with very restricted diets an easy to use meal planning tool and recipes for their favorite Thanksgiving dinners at DaVita.com.
National HealthCare Corporation, a publicly traded long-term health care company, today announced net income available to common shareholders for the quarter ended March 31, 2012 of $10,508,000 compared to $16,556,000 for the quarter ended March 31, 2011, a decrease of 36.5%.
By the time people with Alzheimer's disease start exhibiting difficulty remembering and thinking, the disease has been developing in their brains for two decades or more, and their brain tissue already has sustained damage. As the disease progresses, the damage accumulates, and their symptoms worsen.
Treatment with intravenous low-molecular-weight iron dextran seems to be an effective alternative for patients with nondialysis chronic kidney disease who remain anemic despite receiving oral iron and erythropoiesis-stimulating agents.
› Verified 2 days ago
Arthur J. Brock, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7424 Greenville Ave, Suite 206, Dallas, TX 75231 Phone: 214-363-2004 Fax: 214-378-7483 | |
Dr. Monisha Parvin Gidvani, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8160 Walnut Hill Ln, Suite 210, Dallas, TX 75231 Phone: 214-345-2318 | |
Dr. Enrique Pinkusiewicz, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6546 Lyndon B Johnson Fwy, Dallas, TX 75240 Phone: 972-385-1333 Fax: 972-385-1080 | |
Dr. Dennis Rahim Abbas, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6300 Samuell Blvd Ste 154, Dallas, TX 75228 Phone: 214-388-8898 Fax: 214-388-7898 | |
Rebecca Pedersen, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7777 Forest Ln Ste D550, Dallas, TX 75230 Phone: 972-566-7009 | |
Clara Leigh Telford, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3500 Gaston Ave, Dallas, TX 75246 Phone: 214-820-2361 | |
Patrick M. Weix, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-0624 Fax: 214-645-0078 |